Pharma Foods International Co., Ltd.

2929・Prime Market・Foods

2929・Prime Market・Foods

Pharma Foods International Co., Ltd.2929

Reference Indicators

Market Cap

174¥100M

P/E (Forecast)

11.6x

P/B

1.5x

Dividend Yield (Forecast)

4.19%

ROE

3.2%

EV/EBITDA

6.6x

Financial Summary

Unit: ¥M

Item	2021Jul 2021	2022Jul 2022	2023Jul 2023	2024Jul 2024	2025Jul 2025
Net Sales	46,752	60,185	68,572	62,147	65,260
Cost of Sales	7,027	12,077	13,293	13,395	12,676
Gross Profit	39,724	48,108	55,279	48,751	52,583
SG&A Expenses	34,051	47,028	51,669	43,638	50,215
Operating Income	5,673	1,080	3,610	5,113	2,367
Non-operating Income	114	228	169	285	472
Non-operating Expenses	20	43	239	150	286
Ordinary Income	5,767	1,264	3,540	5,249	2,553
Extraordinary Income	—	160	8	10	—
Extraordinary Losses	1	1	6	225	118
Pre-tax Income	5,765	1,423	3,542	5,034	2,434
Income Taxes	1,924	1,797	462	1,828	2,066
Net Income	3,841	-374	3,081	3,205	368
EBITDA	5,854	1,600	4,156	6,020	3,152
Gross Margin	85.0%	79.9%	80.6%	78.4%	80.6%
Operating Margin	12.1%	1.8%	5.3%	8.2%	3.6%
ROA	18.3%	-1.2%	8.5%	8.8%	1.1%
ROE	57.5%	-4.8%	36.9%	30.2%	3.2%

Segment Performance

Unit: ¥M

2025

Segment	Net Sales	Operating Income	Operating Margin
Bto B事業	8,182	1,248	15.3%
Bto C事業	56,730	3,703	6.5%
バイオメディカル事業	331	-378	-114.2%
その他	15	-10	-66.7%

Disclaimer